49855-91-6

Basic information

• Product Name: (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid
• Synonyms: (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid;N-Cbz-N'-Boc-L-2,4-Diaminobutyric acid;Z-L-DAB(BOC)-OH;(S)-2-(((Benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid;Z-Dab(Boc)
• CAS NO: 49855-91-6
• Molecular Formula: C₁₇H₂₄N₂O₆
• Molecular Weight: 352
• Mol File: 49855-91-6.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 569.6±50.0 °C(Predicted)
• Appearance: /
• Density: 1.213
• Storage Temp.: 2-8°C
• PKA: 3.88±0.10(Predicted)
• CAS DataBase Reference: (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid(49855-91-6)
• EPA Substance Registry System: (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid(49855-91-6)

Safety Data

• Hazardous Substances Data: 49855-91-6(Hazardous Substances Data)

Usage

General Description

"(2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid" is a complex organic molecule with several functional groups. It has a core structure of a four-carbon butanoic acid, suggesting that it belongs to the class of compounds known as amino acids due to the presence of amino groups attached to its carbon chain. The amino groups are adorned by side chains featuring carbonyl groups that have been further substituted by dimethylethoxy and phenylmethoxy groups. (2S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid, like other amino acids, may play a role in biochemical reactions within organisms. However, specific properties, uses or roles of this particular compound are not explicitly provided, and would require further research or information.

InChI:InChI=1S/C17H24N2O6/c1-17(2,3)25-15(22)18-10-9-13(14(20)21)19-16(23)24-11-12-7-5-4-6-8-12/h4-8,13H,9-11H2,1-3H3,(H,18,22)(H,19,23)(H,20,21)/t13-/m0/s1

Upstream product

• 3350-14-9 (S)-2-Benzyloxycarbonylamino-4-tert-butoxycarbonylamino-butyric acid methyl ester 
• 182618-33-3 (S)-4-Amino-2-benzyloxycarbonylamino-butyric acid methyl ester 
• 13907-82-9 N²-benzyloxycarbonyl-L-glutamine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 62234-40-6 (2S)-2-{[(benzyloxy)carbonyl]amino}-4-(dimethylamino)butanoic acid 
• 501-53-1 benzyl chloroformate 
• 10270-94-7 4--L-2,4-diaminobutyric acid 

Downstream Products

• 125156-36-7 2--4--L-2,4-diaminobutyric p-nitrophenyl ester 
• 1026636-40-7 [(2-benzyloxycarbonylamino-4-tert-butoxycarbonylamino-butyryl)-(2,2-dimethoxy-ethyl)-amino]-acetic acid tert-butyl ester 
• 244185-29-3 2--4--L-2,4-diaminobutyric amide 
• 1111629-70-9 C₂₇H₃₃N₅O₁₀ 
• 1111629-72-1 C₂₇H₂₉N₅O₉ 
• 1111629-68-5 C₂₁H₂₇N₃O₇ 
• 1111629-67-4 C₂₁H₂₉N₃O₇ 
• 1111629-69-6 C₂₀H₂₅N₃O₇ 

Relevant articles and documents

COMPOUNDS

Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and

Macrocyclic hexaoxazoles: Influence of aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity

A series of 24-membered macrocyclic hexaoxazoles containing one or two aminoalkyl substituents was synthesized and evaluated for cytotoxicity and for their ability to selectively stabilize G-quadruplex DNA and RNA. The most cytotoxic analog 4a, with IC50 values of 25 and 130 nM using KB3-1 and RPMI 8402 cells, is efficacious in vivo in athymic nude mice with a human tumor xenograft from the breast cancer cell line MDA-MB-435.

Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors

A series of novel transglutaminase inhibitors was prepared, based on the scaffold of a commonly used peptide substrate and bearing an electrophilic maleimide group. These compounds were evaluated in vitro and shown to lead to irreversible inactivation of tissue transglutaminase. Comparison with inhibitors studied previously provides insight into the steric environment of the enzyme active site.